Viewing nowOlmesartan Medoxomil 10 mg Tablet
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

MFDS item code 201101852 · Approved 2011.03.31 · Insurance code 645404070
Treatment of essential hypertension
Essential hypertension is a condition characterized by persistently high blood pressure; this medication helps regulate blood pressure within normal ranges to protect cardiovascular health. Regular use may reduce the risk of complications such as heart disease and stroke related to hypertension. It also dilates blood vessels to improve blood circulation and lessen the overall burden on the body. This medication is most effective when used alongside lifestyle changes. It is used to alleviate symptoms of essential hypertension and to prevent complications.
<Adults> The recommended initial dose is 10mg once daily and may be taken with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dosage adjustment is necessary when this medicine is administered to patients aged 65 years and older. No overall differences in efficacy and safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary in patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily and may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm or death to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients allergic to any of the components of this drug, pregnant or breastfeeding women, patients undergoing kidney dialysis, patients with severe liver disease, and patients with bile duct obstruction should not take this medication. Patients with reduced blood volume or salt deficiency may experience symptoms of low blood pressure, so the condition should be thoroughly checked before starting treatment, and appropriate measures should be taken immediately if low blood pressure occurs. This medication can affect kidney function, so patients with kidney disorders or kidney transplant recipients should regularly monitor kidney function and electrolyte levels through blood tests. Due to the blood pressure-lowering effect, dizziness may occur, so caution is advised during hazardous activities such as working at heights or driving. During treatment, caution is needed when taking potassium-sparing diuretics or potassium supplements as blood potassium levels may increase. Use with non-steroidal anti-inflammatory drugs may increase the risk of kidney function deterioration, so patients should consult their doctor and regularly check fluid intake and kidney function. Using this medication during pregnancy may cause serious problems such as impaired kidney function in the fetus, low amniotic fluid, and craniofacial deformities; therefore, it is crucial to inform healthcare providers if planning to become pregnant or if pregnant. Breastfeeding women should be cautious as this medication may pass to breast milk, and the baby could exhibit adverse reactions; it is recommended to either stop breastfeeding or discontinue the medication. Safety and efficacy for pediatric patients have not yet been established, so it is advisable for children not to take this medication. In case of overdose, symptoms such as low blood pressure, palpitations, and bradycardia may occur; immediate medical assistance should be sought, and appropriate emergency treatment may be required. This medication is known to have a low risk of carcinogenicity or genotoxicity, even with prolonged use; however, any unusual symptoms during use should prompt immediate consultation with healthcare providers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture entry, ideally at a temperature between 1 to 25 degrees Celsius. Storing it this way can maintain the drug's effectiveness and prevent deterioration.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 10mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.